Registrations have closed.
Advancing understanding of Alzheimer’s disease using multiomics spatial biology
86 86 people viewed this event.
The complexity of biological systems and diseases, such as Alzheimer’s disease, necessitates spatial multiomics techniques to gain a holistic understanding of cell-cell interactions and communication. A singular approach to spatial multiomics is possible with MALDI Imaging, including label-free imaging of small molecules, lipids, drugs, and glycans. Additionally, with technology developed by AmberGen, Inc., photocleavable mass-tag (PCMT) conjugated affinity probes are available for antibodies, oligos, and lectins.
Key Learning Objectives:
- Learn the spatial biology utility of MALDI Imaging
- Understand multiomics workflows and the applications to disease-based research
Who Should Attend:
- Researchers interested in multiomics brain analysis
- Investigators researching Alzheimer’s disease
